Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation-Reference-Cited by-同舟云学术

Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation

Published:2020-03 Issue:3 Volume:41 Page:288-293
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:Nuclear Medicine Communications

Author:

Pourhassan Shamchi Sara,Zirakchian Zadeh Mahdi,Østergaard Brian,Kim Jennifer,Raynor William Y.,Khosravi Mohsen,Taghvaei Raheleh,Nielsen Anne L.,Gerke Oke,Werner Thomas J.,Holdgaard Paw,Abildgaard Niels,Revheim Mona-Elisabeth,Høilund-Carlsen Poul Flemming,Alavi Abass

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Candidate mechanisms for chemotherapy-induced cognitive changes

2. Neurotoxic Complications of Chemotherapy in Patients with Cancer

3. Cisplatin-based therapy: a neurological and neuropsychological review

4. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma

5. Chemotherapy-related cognitive impairment in older patients with cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of conventional and novel PET radiotracers in assessment of myeloma bone disease;Bone;2024-02

2. Significance of PET/CT Imaging in Myeloma Assessment: Exploring Novel Applications beyond Osteolytic Lesion Detection and Treatment Response;Onco;2024-01-09

3. Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?;Aging and disease;2022

4. Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk;Nuclear Medicine Communications;2020-12-14

5. Progression of Alzheimer’s Disease by Self-Reported Cancer History in the Alzheimer’s Disease Neuroimaging Initiative;Journal of Alzheimer's Disease;2020-07-21